Scott Schoenhaus
Stock Analyst at Keybanc
(1.97)
# 2,816
Out of 4,829 analysts
102
Total ratings
34.83%
Success rate
-7.84%
Average return
Main Sectors:
Stocks Rated by Scott Schoenhaus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SDGR Schrödinger | Maintains: Overweight | $30 → $32 | $23.91 | +33.84% | 5 | Apr 16, 2025 | |
| SLP Simulations Plus | Maintains: Overweight | $32 → $40 | $30.02 | +33.24% | 3 | Apr 16, 2025 | |
| PHR Phreesia | Maintains: Overweight | $30 → $28 | $25.62 | +9.29% | 7 | Apr 16, 2025 | |
| ODD Oddity Tech | Maintains: Overweight | $52 → $50 | $71.00 | -29.58% | 3 | Apr 16, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $110 → $100 | $90.44 | +10.57% | 5 | Apr 16, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $7 → $5 | $4.13 | +21.07% | 6 | Apr 16, 2025 | |
| DOCS Doximity | Maintains: Overweight | $83 → $70 | $59.19 | +18.26% | 3 | Apr 16, 2025 | |
| CERT Certara | Maintains: Overweight | $15 → $18 | $11.98 | +50.25% | 4 | Apr 16, 2025 | |
| ABCL AbCellera Biologics | Maintains: Overweight | $4 → $5 | $2.03 | +146.31% | 5 | Apr 16, 2025 | |
| ABSI Absci | Maintains: Overweight | $5 → $9 | $2.75 | +227.27% | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $285 → $255 | $237.05 | +7.57% | 15 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $10 | $4.33 | +130.95% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $7 | $8.26 | -15.25% | 3 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $6 | $4.32 | +38.89% | 5 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $4.5 | $3.02 | +49.01% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $11 | $5.57 | +97.49% | 6 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $21.19 | - | 5 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $25.78 | - | 8 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $7.11 | - | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $180 → $250 | $148.99 | +67.80% | 2 | Apr 16, 2021 |
Schrödinger
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $32
Current: $23.91
Upside: +33.84%
Simulations Plus
Apr 16, 2025
Maintains: Overweight
Price Target: $32 → $40
Current: $30.02
Upside: +33.24%
Phreesia
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $28
Current: $25.62
Upside: +9.29%
Oddity Tech
Apr 16, 2025
Maintains: Overweight
Price Target: $52 → $50
Current: $71.00
Upside: -29.58%
HealthEquity
Apr 16, 2025
Maintains: Overweight
Price Target: $110 → $100
Current: $90.44
Upside: +10.57%
Health Catalyst
Apr 16, 2025
Maintains: Overweight
Price Target: $7 → $5
Current: $4.13
Upside: +21.07%
Doximity
Apr 16, 2025
Maintains: Overweight
Price Target: $83 → $70
Current: $59.19
Upside: +18.26%
Certara
Apr 16, 2025
Maintains: Overweight
Price Target: $15 → $18
Current: $11.98
Upside: +50.25%
AbCellera Biologics
Apr 16, 2025
Maintains: Overweight
Price Target: $4 → $5
Current: $2.03
Upside: +146.31%
Absci
Apr 16, 2025
Maintains: Overweight
Price Target: $5 → $9
Current: $2.75
Upside: +227.27%
Jan 8, 2025
Maintains: Overweight
Price Target: $285 → $255
Current: $237.05
Upside: +7.57%
Jan 8, 2025
Maintains: Overweight
Price Target: $12 → $10
Current: $4.33
Upside: +130.95%
Jan 8, 2025
Maintains: Overweight
Price Target: $10 → $7
Current: $8.26
Upside: -15.25%
Jan 8, 2025
Maintains: Overweight
Price Target: $7 → $6
Current: $4.32
Upside: +38.89%
Dec 9, 2024
Initiates: Overweight
Price Target: $4.5
Current: $3.02
Upside: +49.01%
Nov 13, 2024
Maintains: Overweight
Price Target: $10 → $11
Current: $5.57
Upside: +97.49%
May 10, 2024
Downgrades: Sector Weight
Price Target: n/a
Current: $21.19
Upside: -
Oct 11, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $25.78
Upside: -
Sep 16, 2022
Initiates: Sector Weight
Price Target: n/a
Current: $7.11
Upside: -
Apr 16, 2021
Upgrades: Overweight
Price Target: $180 → $250
Current: $148.99
Upside: +67.80%